XML 23 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Balance, shares at Dec. 31, 2017     32,332,000           615,000
Balance at Dec. 31, 2017 $ 531,719 $ 274 $ 323 $ 271,957 $ 274,562 $ 624 $ (4,366) $ (350) $ (10,757)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 63,809       63,809        
Foreign currency translation adjustment (3,241)           (3,241)    
Adjustment to post-retirement healthcare benefit liability, net of taxes 723           723    
Stock compensation expense 9,189     9,189          
Net settlement of restricted stock units, shares     460,000           181,000
Net settlement of restricted stock units $ (7,165)   $ 5 (5)         $ (7,165)
Issuance of restricted stock, shares     7,000            
Stock options exercised, shares 87,907   88,000            
Stock options exercised $ 1,385     1,384          
Balance, shares at Dec. 31, 2018     32,887,000           796,000
Balance at Dec. 31, 2018 596,693 1,582 $ 329 282,525 338,995 1,582 (7,234)   $ (17,922)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 65,091       65,091        
Foreign currency translation adjustment 1,766           1,766    
Adjustment to post-retirement healthcare benefit liability, net of taxes 77           77    
Stock compensation expense $ 12,570     12,570          
Accounting standards update us-gaap:AccountingStandardsUpdate201602Member                
Net settlement of restricted stock units, shares     255,000           110,000
Net settlement of restricted stock units $ (4,305)   $ 3 (3)         $ (4,305)
Issuance of restricted stock, shares     8,000            
Stock options exercised, shares     42,000            
Stock options exercised 490     490          
Balance, shares at Dec. 31, 2019     33,192,000           906,000
Balance at Dec. 31, 2019 673,964 $ (291) $ 332 295,582 405,668 $ (291) (5,391)   $ (22,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 64,566       64,566        
Foreign currency translation adjustment 3,301           3,301    
Adjustment to post-retirement healthcare benefit liability, net of taxes (371)           (371)    
Stock compensation expense $ 8,173     8,173          
Accounting standards update us-gaap:AccountingStandardsUpdate201613Member                
Net settlement of restricted stock units, shares     296,000           122,000
Net settlement of restricted stock units $ (6,656)   $ 4 (4)         $ (6,656)
Issuance of restricted stock, shares     4,000            
Stock options exercised, shares 75,909   76,000            
Stock options exercised $ 1,119     1,119          
Balance, shares at Dec. 31, 2020     33,568,000           1,028,000
Balance at Dec. 31, 2020 $ 743,805   $ 336 $ 304,870 $ 469,943   $ (2,461)   $ (28,883)